JPM CBRN Medical plays a vital role in enhancing the DoW’s strategy to prevent, diagnose, and treat the effects of CBRN threats and emerging infectious diseases.
Opportunities through the public-private partnership TechWatch help JPM CBRN Medical develop and acquire safe, effective, and innovative medical solutions and systems to combat CBRN and other emerging infectious diseases.